Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
TIMESPAN
Feasibility and Acceptability of Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
2 other identifiers
interventional
17
1 country
1
Brief Summary
The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the feasibility, fidelity and preliminary acceptability of a TRE intervention among Native Hawaiian/Pacific Islander women at risk for developing endometrial cancer, and to provide proof of principle that TRE can improve metabolic health in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2021
CompletedStudy Start
First participant enrolled
February 18, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedNovember 30, 2023
November 1, 2023
1.3 years
February 8, 2021
November 28, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Proportion of Women Referred that are Consented
Feasibility of the TRE intervention will be measured by calculating a proportion (%) of women who were referred that were consented into the study. The study will be considered feasible if \> 70% of participants are consented and retained.
From baseline to Visit 5 (Week 14)
Attrition as a Function of Time
Number of participants who withdraw throughout the course of the study.
From baseline to Visit 5 (Week 14)
Percent of Scheduled Assessments Completed
Feasibility of the TRE intervention will be assessed by calculating a percentage of scheduled biospecimen collection and questionnaires completed.
From baseline to Visit 5 (Week 14)
Number of TRE-Adherent Days per Week
Feasibility of the TRE intervention will be measured by calculating the number of TRE-adherent days per week. Participants will be considered adherent if they fasted between 14-18 hours per day during the TRE phase according to a mealtime log. The study will be considered feasible if women adhere to the TRE protocol on average 5 days per week.
From baseline to Visit 5 (Week 14)
Percentage of Meals Delivered On Schedule
Feasibility of the TRE intervention will be measured by calculating a percentage of meals delivered on schedule.
From baseline to Visit 5 (Week 14)
Fidelity of Time Restricted Eating (TRE) Intervention
Fidelity will be evaluated as a percentage of protocol checklist items delivered as intended with a goal of 90%.
From baseline to Visit 5 (Week 14)
Secondary Outcomes (9)
Change in blood pressure assessed via electronic blood pressure monitor
Baseline (Visit 1), Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Change in waist circumference assessed via measuring tape
Baseline (Visit 1), Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Change in BMI assessed via height and weight
Baseline (Visit 1), Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Change in fasting blood glucose assessed via blood draw
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Change in HOMA-IR assessed via blood draw
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
- +4 more secondary outcomes
Study Arms (2)
Time Restricted Eating (TRE) Schedule
EXPERIMENTALFor 8 weeks out of the 14-week randomized dietary crossover study, women will receive prepared frozen lunch and dinner meals as per the control schedule, but will be asked to consume daily meals, snacks, and calories-containing beverages within an 8 to 10-hour period that fits their schedule. The fasting period will ramp up during the first week (Days 1-3, 12-14 h per day, Days 4-6, 14-16 h per day, Days 7+, 16 h per day).
Control Schedule
NO INTERVENTIONFor 4 weeks out of the 14-week randomized dietary crossover study, women will receive prepared frozen lunch and dinner meals, and a standardized breakfast and snacks menu. All meals and snacks will be culturally competent, and meal plans will be individualized to meet weight maintenance energy requirements.
Interventions
\[See arm/group descriptions\]
Eligibility Criteria
You may qualify if:
- All Aims:
- Native Hawaiian/Pacific Islander females aged 18 years or older
- Overweight or obese (BMI\>25kg/m2) OR have a history of non-insulin dependent diabetes OR have a history of complex atypical endometrial hyperplasia
- Have a working cell phone that can download an App
- Able to use cell phone during day (e.g. at work)
- Not a night shift worker
- Applicable Only to Aims 2 \& 3:
- Able to attend study visits at the Huntsman Cancer Institute Center for HOPE
You may not qualify if:
- All Aims:
- Unable to provide informed consent
- Applicable Only to Aims 2 \& 3:
- Necessity of a special diet that precludes adjustment of meal timing and/or macronutrient content
- Have a history of insulin dependent diabetes
- Have a history of hysterectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Playdon, PhD, MPH
University of Utah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Investigator
Study Record Dates
First Submitted
February 8, 2021
First Posted
February 21, 2021
Study Start
February 18, 2021
Primary Completion
June 10, 2022
Study Completion
September 30, 2022
Last Updated
November 30, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share